2 completed, 2 terminated, 1 recruiting, 1 unknown. 3 Phase 2, 1 Not applicable, 1 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Terminated 2, Completed 1 |
| Not applicable | 1 | Recruiting 1 |
| Phase 3 | 1 | Completed 1 |
| Phase 4 | 1 | Unknown 1 |
Follow lusutrombopag: new trials by email Literature Review of lusutrombopag trials Research Report on lusutrombopag
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Lusutrombopag After Allogeneic Hematopoietic Stem Cell Transplantation Lusutrombopag - Patients With Hematologic Disorders After Allogeneic Hematopoietic Stem Cell Transplantation, Hematologic Disorders | Not applicable | Recruiting | The General Hospital of Western Theater Command | 45 | 2026-01-13 | 2026-03-25 |
| A Prospective Study on the Treatment of Recurrent/Refractory/Intolerable NSAA With Lusutrombopag Lusutrombopag - Aplastic Anemia | Phase 4 | Unknown | Peking Union Medical College Hospital | 40 | 2024-06-01 | 2024-05-23 |
| Lusutrombopag in the Treatment of Immune Thrombocytopenia (ITP) Lusutrombopag Oral Tablet - Idiopathic Thrombocytopenic Purpura, Immune Thrombocytopenia | Phase 2 | Completed | Institute of Hematology & Blood Diseases Hospital, China | 17 | 2024-04-17 | 2025-12-19 |
| Safety and Efficacy Study of Lusutrombopag for Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Elective Invasive Procedures Lusutrombopag, Placebo - Chronic Liver Disease, Thrombocytopenia | Phase 3 | Completed | Shionogi | 215 | 2015-06-15 | 2018-10-30 |
| An Open-label Safety Study of Lusutrombopag (S-888711) in Adults With Chronic Immune Thrombocytopenia (ITP) Lusutrombopag - Immune Thrombocytopenia | Phase 2 | Terminated | Shionogi | 19 | 2010-04-29 | 2021-02-26 |
| A Study to Investigate the Efficacy and Safety of Lusutrombopag (S-888711) Tablets Administered to Adults With Immune Thrombocytopenia (ITP) Placebo, Lusutrombopag - Immune Thrombocytopenia (ITP) | Phase 2 | Terminated | Shionogi | 20 | 2010-03-18 | 2021-03-18 |
Hematologic Diseases (3) · Purpura, Thrombocytopenic, Idiopathic (3) · Thrombocytopenia (3) · Blood Platelet Disorders (2) · Purpura, Thrombotic Thrombocytopenic (2) · Anemia, Aplastic (1) · Recurrence (1)
Shionogi (3) · Institute of Hematology & Blood Diseases Hospital, China (1) · Peking Union Medical College Hospital (1) · The General Hospital of Western Theater Command (1)
China (3) · United States (2)
Bing Bing, PhD (1) · Zhang Lei, MD (1)
2014 (1)